| Q3 (Sep '09) | 2008 | |
| Net profit margin | - | - |
| Operating margin | - | - |
| EBITD margin | - | - |
| Return on average assets | -737.19% | -378.12% |
| Return on average equity | - | - |
| Employees | 4 | - |
| Donald W. Paterson | Chairman of the Board | |
| Wayne D. Cockburn | President, Chief Executive Officer, Director | |
| Alan J. Goldman M.D. | Vice President - Clinical and Medical Affairs | |
| Steeve Asselin | Vice President - Research & Development | |
| George D. Angelidis | Director | |
| Craig W. Lunsman | Director |